William C. Olson, Senior VP, Research and Develo at PROGENICS PHARMACEUTICALS INC (PGNX), sold 2,872 shares at $7.09 ($20K) on 2011-06-21, disclosed to the SEC on 2011-06-22.
Scheduled sale ($20k) by Senior VP, Research and Develo under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.09 | 2,766 | $20K | 96.3% |
| 2 | $7.11 | 106 | $754 | 3.7% |
| Total | $7.09 avg | 2,872 | $20K | 100% |
| Filing → |
| PGNX | SELL | 2007-12-05 | $76K | — | Filing → |
| PGNX | SELL | 2006-06-22 | $22K | — | Filing → |
| PGNX | SELL | 2006-05-08 | $336K | — | Filing → |